Loading clinical trials...
Loading clinical trials...
An Expanded Compassionate Access Protocol for a Single Subject Who Has Completed 24-Weeks of Treatment in PRO140_CD02 Study
Conditions
Interventions
PRO 140
Locations
1
United States
CD02 EA Investigational site
Orlando, Florida, United States
Last Updated
March 13, 2018
NCT04929028
NCT07071623
NCT01875588
NCT03087253
NCT07199335
NCT05419024
Lead Sponsor
CytoDyn, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions